---
title: "Curaleaf rebuts Aurora, reaffirms offer citing shareholder premium and operational gaps"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296893345.md"
description: "Curaleaf reaffirmed its unsolicited offer for Aurora, citing a substantial shareholder premium and highlighting Aurora's operational gaps. Curaleaf accused Aurora of refusing substantive talks and noted significant performance disparities, including Aurora's C$400M+ in impairments versus Curaleaf's 56% stock rise. Key metrics cited include Aurora's lower cultivation yields and negative operating cash flow compared to Curaleaf."
datetime: "2026-08-25T10:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296893345.md)
  - [en](https://longbridge.com/en/news/296893345.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296893345.md)
generator: "portal-rs"
---

# Curaleaf rebuts Aurora, reaffirms offer citing shareholder premium and operational gaps

**Curaleaf issued a public response to Aurora's statements and reiterated its unsolicited offer, saying it provides a substantial premium and urges Aurora to engage.**

**Key Highlights:**

-   Curaleaf says Aurora refused substantive talks, NDAs and site visits despite Curaleaf's readiness to meet anytime to discuss a deal.
-   Curaleaf claims Aurora's multi-year turnaround cost C$400M+ in impairments and transformation costs, with shares down ~35% YTD to Aug 10, 2026.
-   Curaleaf notes its shares rose ~56% over the same period and says the market reacted positively to Curaleaf's offer.
-   Curaleaf disputes Aurora's selective metrics, citing Aurora's June quarter adjusted EBITDA down 63% vs March and negative operating cash flow of C$4.4M.
-   Curaleaf highlights cultivation yield discrepancy: Aurora's audited fiscal 2026 shows 114 g/plant vs Curaleaf's yields more than double that figure.

Original SEC Filing: Curaleaf Holdings, Inc. \[ CURLF \] - 8-K - Aug. 24, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ACB.US](https://longbridge.com/en/quote/ACB.US.md)
- [CURLF.US](https://longbridge.com/en/quote/CURLF.US.md)

## Related News & Research

- [Curaleaf issues fact sheet defending bid to buy Aurora Cannabis](https://longbridge.com/en/news/298328943.md)
- [Curaleaf defends bid for Aurora, reiterates offer as “best path” for shareholders](https://longbridge.com/en/news/297805701.md)
- [Curaleaf Responds to Aurora Circular, Reiterates 45% Premium Offer and Strategic Rationale](https://longbridge.com/en/news/297815366.md)
- [Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid](https://longbridge.com/en/news/297808998.md)
- [Aurora Cannabis urges shareholders to reject Curaleaf takeover bid](https://longbridge.com/en/news/297774500.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**